Congenital hyperinsulinism (CHI) is a rare condition characterized by severe and persistent hypoglycemia due to dysregulated insulin secretion from pancreatic β-cells (1) that represents a substantial burden to affected children, their families, and the National Health Service (NHS) (∼£3.5 million annually) (2, 3). Here, INS is linked to congenital isolated hyperinsulinism.